Upgrade to SI Premium - Free Trial

Varex Imaging Corporation (VREX) Misses Q3 EPS by 19c

August 12, 2020 4:08 PM

Varex Imaging Corporation (NASDAQ: VREX) reported Q3 EPS of ($0.20), $0.19 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $171 million versus the consensus estimate of $171.09 million.

3QFY20 Summary

“During the third quarter of fiscal year 2020, the impact of COVID-19 resulted in declining sales and a sizeable unfavorable shift in product mix that reduced our revenues, margins and profitability. While sales of CT tubes and other radiographic products used in COVID-19 related diagnostic imaging applications increased significantly, total revenues declined 13% from the year ago quarter due to sales declines in other products, such as those for oncology, dental and industrial applications,” said Sunny Sanyal, Chief Executive Officer of Varex.

In response to the decline in revenues and gross margin, Varex has taken a number of actions that are expected to reduce annual operating costs by more than $25 million, including:

“We believe that these and other actions, as well as a continued focus on pursuing productivity gains, will better position Varex when the imaging markets recover from the downturn caused by COVID-19,” said Sanyal.

For earnings history and earnings-related data on Varex Imaging Corporation (VREX) click here.

Categories

Corporate News Earnings Management Comments

Next Articles